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ABSTRACT: There is currently an increasing need for new substances or secondary metabolites 
from natural products with antiviral activity. The aim of this study was to determine the antiviral 
activity of Rhizophora mangle L. against DNA and RNA virus. With this aim, R. mangle aqueous 
bark extract (RMABE) and its butanolic fraction (BF-RMABE) were evaluated for the cytotoxicity 
and cytopathic effect inhibition assay. The selectivity index was also calculated. An in vitro 
antiviral activity was demonstrated for RMABE and BF-RMABE against the RNA prototype of 
Canine Distemper Virus (CDV) (CI50 83.30 and 86.10 μg/mL, respectively) and the DNA 
prototype of Bovine Herpes Virus type 1 (BHV-1) (CI50 87.50 and 90.63 μg/mL, respectively). 
The results showed the promising antiviral effect of the evaluated R. mangle extracts, suggesting 
the need for further tests to confirm its in vivo activity.   
Key words: in vitro antiviral activity, CDV, VHB-1, polyphenols, Rhizophora mangle. 
RESUMEN: Actualmente existe una creciente necesidad de nuevas sustancias o metabolitos 
secundarios a partir de productos naturales con actividad antiviral. El objetivo de este estudio fue 
determinar la actividad antiviral de Rhizophora mangle L. frente a virus prototipos de ADN y ARN. 
En este sentido, se evaluó el extracto acuoso de corteza de R. mangle (RMABE) y su fracción 
butanólica (BF-RMABE) mediante las pruebas de citotoxicidad e inhibición del efecto citopático. 
De la relación entre estas pruebas se calculó el índice de selectividad. Se demostró, además, 
actividad antiviral in vitro para RMABE y BF-RMABE frente al virus del moquillo canino (CDV) 
como prototipo de virus ARN (CI50 83,30 y 86,10 μg/mL, respectivamente) y el Herpes Virus 
Bovino tipo 1 (BHV-1) como prototipo de ADN (CI50 87,50 y 90,63 μg/mL, respectivamente). 
Los extractos de R. mangle evaluados, mostraron efecto antiviral, lo que sugiere la necesidad de 
pruebas adicionales para confirmar su actividad in vivo. 
Palabras clave: actividad antiviral in vitro, CDV, BHV-1, polifenoles, Rhizophora mangle. 
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INTRODUCTION 
Plants are a natural source of therapeutically 
recognized compounds with diverse biological 
activities offering treatment for several human 
and animal diseases. Viral infections represent 
an important research focus for the 
identification of new phytopharmaceuticals 
(1).  
The discovery of antivirals is a relatively 
recent issue. At present, the antiviral therapy is 
mostly limited to human diseases with few 
applications in veterinary medicine. Currently 
the research carried out on antivirals against 
animal viruses is mostly aimed at providing 
new insights for the development of 
chemotherapeutics against phylogenetically 
correlated human viruses. There is in fact an 
increasing interest to the animals and their 
pathologies as possible models for human 
diseases. In the veterinary field, antivirals may 
represent an alternative when vaccination is not 
feasible in case of sudden epidemic outbreaks 
and they would offer advantages when in-
contact animals need protection during 
emergency vaccinations. Although the primary 
focus has been on the synthetic products, the 
number of natural compounds with antiviral 
action for different DNA and RNA viruses that 
are being studied is increasing (2). 
Tannins are secondary metabolites 
characterized by their polyphenol nature and 
they can be found in many plants as individual 
components or forming complex mixtures (3). 
There is a wide range of the pharmacological 
activity of the plants containing polyphenols as 
reported by Keerthi et al. (4). The wide 
biological activities of polyphenols have been 
related to their ability to bind macromolecules 
such as proteins and polysaccharides (5,6,7). 
The antioxidant and radical scavenging 
activities of tannins are often linked to the 
interaction with metal ions, forming chelated 
complexes (8). The antiviral activity of the 
phenolic compounds against several DNA 
and/or RNA viruses has been well documented 
by Chattopadhay et al. (9), Bhanuprakash et al. 
(10), Elsebai et al. (11). Thus, Gamaleldin et 
al. (12), reported that plants, rich in 
chlorogenic acids (CGAs), caffeic acids and 
their derivatives, have been found to exert the 
antiviral effects against influenza virus 
neuraminidase. The crude and aqueous extract 
and the ethyl acetate fractions of Trichilia 
catigua (a Brazilian native plant) have been 
reported to exert the antiviral activity during 
the replication of the Herpes Simplex Virus 
(HSV-1), BHV-1 and Poliovirus (PV-1), which 
are responsible for important diseases in 
humans and animals (13). 
The phenolic compound eugeniin 
(ellagitannin), extracted from Geum japonicum 
and Syzygiuma romaticum, clearly 
demonstrated the anti-HSV activity by 
decreasing the DNA polymerase activity (14). 
In a systematic study of the antiviral activity 
of a very wide range of natural products, Van 
den Berghe et al. (15) concluded that 
polyphenols act principally by binding the 
virus and/or the protein of the host cell 
membrane being able to inhibit the absorption 
of several viruses. Further researches 
demonstrated the capability of polyphenols to 
inactivate proteins from the cell surface, to 
block the viral adsorption and to inhibit the 
viral enzymes such as reverse transcriptase and 
RNA polymeraseand poly (ADP-ribose) (16). 
Steinmann et al. (17) reported the antiviral 
activity of epigallocatechin-3-gallate (EGCG), 
the main constituent of Camellia sinensis 
(green tea), showing different mechanisms of 
action on diverse families of viruses, such as 
Retroviridae, Orthomyxoviridae and 
Flaviviridae, as well as important human 
pathogens such as the human 
immunodeficiency, influenza A and hepatitis C 
viruses. Furthermore, the molecule 
demonstrated to be able to interfere with the 
replication cycle of DNA viruses like hepatitis 
B virus, herpes simplex virus and adenovirus. 
Another example of the antiviral effect of 
polyphenols is that of bakuchiola phenolic 
isoprenoid with novel enantiomer-selective 
anti-influenza A virus activity involving Nrf2 
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activation. Compounds like (+)-(S)-bakuchiol 
and its enantiomer, (-)-(R)-bakuchiol, inhibit 
influenza A viral infection and growth and 
reduce the expression of viral mRNAs and 
proteins in these cells. Furthermore, these 
compounds markedly reduced the mRNA 
expression of the host cell influenza A virus-
induced immune response genes, interferon-β 
and myxovirus-resistant protein 1. 
Interestingly, (+)-(S)-bakuchiol had a greater 
efficacy than (-)-(R)-bakuchiol, indicating that 
chirality influenced the anti-influenza virus 
activity (18). 
Rhizophora mangle L, red mangrove, is 
recognized in the Cuban traditional medicine 
and in different Caribbean countries as well 
(19). Its aqueous bark extract showed to be rich 
in polyphenols (20). R. mangle revealed 
interesting pharmacological effects with 
therapeutic potentiality such as: antimicrobial 
(21), wound healing promoter (22), anti-
inflammatory (23), in the treatment of 
aphthous ulcer (24), antioxidant (25), and 
antiulcerogenic (26). The chemical 
composition of Rhizophora mangle aqueous 
bark extract and its fractions were also studied 
in previous researches (26,27). 
It is worth mentioning that polyphenols may 
modulate the production of IL-2 and interferon 
gamma (IFN-gamma). Thus following that 
logic, it was confirmed that the structural 
diversity of polyphenols present in Rhizophora 
mangle L has a capacity to stimulate the release 
of IL-2, indicating that such polyphenols play 
an important role in the biological regulations 
(27).  
Orf, commonly referred as contagious 
ecthyma, is a highly contagious viral disease 
that causes important economic losses in sheep 
and goats, being one of the most skin 
distressing diseases affecting these species. 
The topical application of Rhizophora mangle 
aqueous bark extract on lambs experimentally 
infected with Orf virus shows a faster healing 
than in the treated group (28).  
The current work researched the in vitro 
antiviral activity of Rhizophora mangle 
aqueous bark extract (RMABE) and its 
butanolic fraction (BF-RMABE) against BHV-
1 and CDV as prototypes of DNA and RNA 
viruses respectively. 
MATERIALS AND METHODS 
Rhizophora mangle aqueous bark extract 
(RMABE) and its butanolic fraction (BF-
RMABE) 
Fresh bark in distilled water (1:7.5 w/v) was 
boiled for 20 min. The plant material was 
separated by filtration and the supernatant 
(RMABE) was freeze-dried and preserved at 4-
8C. 
BF-RMABE fractionation was carried out 
with n-butanol as follow: 50 mL of distilled 
water and 18 g NaCl were added to 1g of 
RMABE. The solution was stirred, heated 
(78C) for 30 minutes and centrifuged at 3000 
rpm for 10 minutes. The precipitate was then 
extracted with n-butanol using Büchi B 811 
Extraction System (upper heating 4, lower 
heating 16, 2:00 hours) and dried by rotary 
evaporation (55C). 
Cells and viruses 
VERO cells (culture collection ATCC® 
number CCL-81™) and MDBK cells (culture 
collection ATCC® number CCL-22) were used 
for the in vitro growth of canine distemper 
virus (CDV) and bovine herpes virus- 1 (BHV-
1) respectively. Cells were cultured at 37 °C in 
a 5 % CO2 atmosphere in Dulbecco’s modified 
Eagle’s medium (Gibco, Invitrogen 
Corporation) supplemented with 10 % fetal 
calf serum (FCS), 2 mmol/L of L-glutamine, 1 
mmol/L of sodium pyruvate and 7.5 % sodium 
bicarbonate. All the cells, medium components 
and virus strains were previously tested for the 
absence of Mycoplasma spp. and Bovine Viral 
Diarrhea virus (BVDV) by PCR assays. 
Bussell-CDV strain and BoHV-1 have been 
propagated in cells using a 2 % FCS medium 
and they were subsequently titrated. The viral 
titer was expressed as the 50 % tissue culture 
infectious dose (TCID50/mL).  
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Cytotoxicity assay 
The cell toxicity of RMABE, BF-RMABE, 
ribavirin (RBV) and HPMPC (S-1-(3-hydroxy-
2-phosphonylmethoxypropyl) cytosine was 
evaluated on the growing cell lines VERO and 
MDBK using a colorimetric assay based on the 
mitochondria metabolization of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) (Sigma, Missouri). The 
toxicity of the compounds and DMSO used to 
dissolve them was measured as previously 
described by Scagliarini et al. (29). The 50 % 
cytotoxic concentration (CC50) was defined as 
the compound concentration able to reduce the 
number of viable cells to 50 % of cell control. 
The CC50 values were expressed as the mean 
± the standard deviation of at least three 
independent experiments. 
Antiviral assays 
The intracellular activity of the plant 
extracts and positive controls 1-β-D-
Ribofuranosyl-1,2,4-triazole-3-carboxamide 
(Ribavirin, RBV) and (S)-1-(3-Hydroxy-2-
phosphonylmethoxypropyl) cytosine 
(HPMPC, Cidofovir, Vistide) against animal 
viruses was evaluated by the cytopathic effect 
(CPE) reduction assay (CPE-reduction assay) 
on confluent cells, using the protocol 
previously described by Scagliarini et al. (29). 
Statistical analysis 
The selectivity index (SI) was obtained by 
calculating the calculating the ratio between 
the cytotoxicity and the antiviral activity 
values. 
The 50 % inhibitory concentration (IC50), 
defined as the compound concentration 
required to reduce viral CPE by 50 % of the 
virus control, was calculated as the mean of 
three independent experiments ± the standard 
deviation. 
RESULTS AND DISCUSSION 
The cytotoxicity assays allowed 
determining the cytotoxic concentration 
(CC50) of RMABE and BF-RMABE in Vero 
and MDBK cells (Table 1). The cytotoxicity 
assessment is clearly an important part of a 
potential antiviral agent evaluation because a 
useful compound should be selective for virus-
specific processes with no or few effects on 
cellular metabolism and not showing toxicity 
against the host (30,31). Additionally, this step 
is critical because the virus uses the cell 
machinery to replicate, and it must be ensured 
that the virus has the ideal conditions for 
growth (32). 
The present results showed relatively low 
CC50 values for RMABE and BF-RMABE in 
Vero and MDBK cells compared to the control 
compounds HPMPC and RBV. These results 
are in accordance with previous results 
obtained with Sesbania virgata extracts 
showing CC50 values between (3.91 and 250 
μg/mL) and (15.62 y 125 μg/mL) for MDBK 
and Vero cells respectively. The polar nature of 
the active ingredient(s) in the antiviral activity 
of this plant was suggested (33). 
Ruibal et al. (34) found high cytotoxicity for 
different polyphenolic fractions obtained from 
Pinus caribaea Morelet var. caribaea in MT4 
cells. Fractions containing condensed tannins 
showed CC50 = 100 μg/mL; while low 
molecular weight phenolics were highly toxic 
to the cells. In this sense, it was previously 
demonstrated that the presence of hydroxyl 
groups is associated to the increment of 
intracellular reactive oxygen species (ROS), 
with consequences in the damage of the cells, 
although the relationship among compounds 
with similar structures and cytotoxicity is still 
unknown for particular types of cells (35).  
Therefore, a Phyllanthus orbicularis extract 
was evaluated using MTT assay and 
cytotoxicity was determined for MDBK, FPH, 
HeLa and HEp-2 cells, showing CC50 values of 
262.05±12.7, 669±36, 212.62±8.37 and 
144.7±3.7 μg/mL, respectively (36). 
However, compounds containing hydroxyl 
groups can interact with iron, copper and other 
metals usually present in culture media and 
fetal bovine sera, intensifying MTT reduction 
and increasing blue coloration. Some 
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compounds can react with iron, generating 
blue-black complexes thatmay influence the 
cytotoxicity estimation through MTT assay 
(30). 
The results obtained in the in vitro antiviral 
assay are shown in Table 1. 
Thus, current results showed antiviral 
activity of RMABE and BF-RMABE against 
BHV-1 and CDV in MDBK and Vero cells, 
respectively. Nevertheless, these preliminary 
results did not show differences between both 
types of viruses and IC50 values were found 
between 83.30 and 90.63μg/mL. To screen the 
antiviral activity of plant extracts, it is 
important to choose animal viruses containing 
the main differentiating features of viral 
morphology, like viruses with no envelope, 
those with an envelope, as well RNA and DNA 
viruses (32). In the current work, a prototype 
DNA virus (BHV-1) and an RNA virus, both 
enveloped, were used. This caused severe 
animal diseases.  Particularly, CDV which is a 
Morbillivirus, is identified as an attractive 
target in the development of antiviral 
molecules, because human and animal tissues 
lack of a known homologue of the RNA-
dependent RNA polymerase (33). 
The current experiment also suggested that 
the evaluated extracts could affect viruses of 
the same genus or families, as well viruses with 
same genetic material. In fact, the topical 
application of Rhizophora mangle aqueous 
bark extracts RMABE and BF-RMABE in the 
treatment of contagious ecthyma in lambs 
experimentally infected with Orf virus 
(Poxviridae family), shows efficacy at the 
initial state of the infection (28). 
Chattopadhay et al. (9) well documented the 
antiviral activity of the plant phenolic 
compounds against several DNA and/or RNA 
viruses. Cellular surface proteins are 
inactivated by polyphenols; they also interfere 
on viral adsorption, inhibit reverse-
transcriptase and viral RNA polymerase, as 
well as DNA and RNA replication (16) 
Besides, studies related to structures and the 
antiviral biological activity of plants revealed 
that the sites and numbers of hydroxyl groups 
of phenols are responsible for their antiviral 
activity (9,15). 
Camellia sinensis (green tea), catechins, 
epigallocatechin gallate (EGCG) have received 
the most attention and they have been 
researched deeply in its antibacterial, antiviral, 
and antifungal activities. EGCG was found to 
prevent influenza virus infections by binding 
the viral hemagglutinin, thereby preventing the 
attachment of viral particles to the target 
receptor cells. The antiviral action mechanisms 
of EGCG vary depending on its target virus 
(38). 
A valuable review about the antimicrobial 
effect of polyphenols including the antiviral 
effect, by Daglia (39), mentioned that the 
TABLE 1. Rhizophora mangle aqueous bark extract (RMABE) and its butanolic fraction (BF-
RMABE), cytotoxicity and the in vitro antiviral evaluation activity./ Extracto acuoso de 
corteza de Rhizophora mangle (RMABE) y su fracción butanólica (BF-RMABE), citotoxicidad 
y actividad de evaluación antiviral in vitro. 
Samples 
MDBK Cells Vero Cells 
 
CC50 
(µg/mL) 
BHV-1  
CC50 
(µg/mL) 
CDV 
IC50 
(µg/mL) 
SI 
IC50 
(µg/mL) 
SI 
RMABE 92.20±15.78 87.50±6.83 1.05 
112.66±21.5
3 
77.50±4.79 1.45 
BF-
RMABE 
120.42±19.7 90.63±9.98 1.33 
106.71±17.8
6 
86.10±12.7 1.24 
CC50:50 % cytotoxic concentration; IC50:50 % inhibitory concentration; SI: selectivity index. 
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activity can be attributable to both direct 
actions against bacteria, virus and fungi, as 
well as to the suppression of microbial 
virulence factors. Rhizophora mangle L shows 
ability to stimulate the in vitro release of IL-2, 
and such results could indicate that the 
polyphenols present in the plant play an 
important role as immune modulator as well 
(27). Gallina et al. (40) report that 
proanthocyanidin A2 extracted from 
Heasculus hyppocastanum exerted in vitro 
antiviral activity against CDV with a higher SI 
compared to Ribavirin. The in vitro antiviral 
activity of chestnut and quebracho wood 
extracts against avian reovirus and 
metapneumovirus has also been demonstrated 
by Lupini et al. (41). 
Thus, Ikuno et al. (34) evaluated Sesbania 
virgata leaf extracts against BHV-1 and HVS-
1 in MDBK and Vero cells. The results showed 
that all the fractions evaluated had a promising 
activity in MDBK cells against BHV-1. On the 
contrary, just two fractions (the most polar) 
showed moderated active in Vero cells against 
both BHV-1 and SHV-1 viruses. Different cell 
substrates were used for each virus. In this 
sense, the obtained results are not conclusive.  
Although the massive use of antivirals in 
animals may be controversial over possible 
resistance, there are several animal diseases 
caused by DNA viruses like Orf and BHV-1 
among others, which induce skin or mucosal 
erosive lesions needed to be treated with 
wound healing compounds. In such cases, 
RMABE and BF-RMABE, according to their 
healing properties (22), would be valuable 
therapeutic options contributing to animal 
welfare during infections. This is in agreement 
with the efficacy observed for these 
compounds in lambs experimental infected 
with contagious ecthyma (28). These viruses 
are quite stable reducing the probability of the 
emergence of resistant strains. 
BHV-1 produces clinical manifestations 
characterized by pustular vulvo vaginitis and 
erosive skin lesions that may be treated with 
the evaluated compounds taking advantage of 
their antiviral effect combined with the wound 
healing properties (22).  In fact, some other 
herperviruses also induce these kinds of 
erosive lesions that could be resolved by the 
potential similar mechanisms of antiviral 
effect. 
Another factor influencing the antiviral 
activity is the virus strain. Thus, Savi et al. (30) 
reported different antiherpetic activities for 
epicatechin, epigaliocatechin and 
epigaliocatechin gallate against KOS and 
29R/acyclovir resistant strains. Epicatechin 
showed the major activity.  
Date and Destache (42) published data from 
various in vitro and in vivo studies carried out 
on epigallocatechin gallate, theaflavins (black 
tea polyphenols), resveratrol, genistein, and 
curcumin, highlighting their potential to 
prevent sexually transmitted infections caused 
by HIV (human immunodeficiency virus), 
HSV (herpes simplex virus) and HPV (human 
papilloma virus), confirming the potential of 
natural products as antiviral agents. 
Moreover, the time and the moment for the 
plant extract sample application determine the 
intracellular or extracellular action. If the 
sample is not evaluated in an assay that is 
suitable for determining its mechanism of 
action, negative false results can be obtained 
and its antiviral potential could be limited. The 
present study evaluated RMABE and BF-
RMABE against BHV-1 and CDV through an 
intracellular mechanism, inhibiting viral 
replication. This is an important issue because 
the severity of viral diseases and the ability of 
viruses to survive intracellularly pose a great 
challenge that is further aggravated by the non-
availability of specific antiviral agents against 
veterinary pathogens (32). Other factors such 
as treatment time and infective viral doses 
could also influence the antiviral activity. 
Besides, an intrinsic constituent of the 
antiviral testing is the determination of a 
selectivity index (SI) towards the supporting 
host cell. The SI refers to the ratio of the 
maximum drug concentration causing either 50 
% or 90 % growth inhibition of normal cells 
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(CC50, CC90) and the minimum drug 
concentration at which 50 % or 90 % of the 
virus is inhibited (IC50, IC90) (43). 
The present results showed low SI values 
for RMABE and BF-RMABE compared to the 
chemical compounds tested for the antiviral 
activity against CDV (43). Ribavirin in Vero 
cells is active against CDV with a time-
dependent antiviral activity. However, 
Ribavirin is approved for use in human, with 
an SI (1.2) in part justified due to its cytostatic 
activity (29). The antiviral and toxic effects are 
not necessarily caused by the same mix 
components in crude extracts; that is why SI is 
not as valued as when it is calculated for the 
pure or synthetic compounds. 
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